Insulin pumps control blood sugar in children with diabetes better than insulin injections, according to a new study.
Insulin pumps control blood sugar in children with diabetes better than insulin injections, according to a new study.
Published in the August 18, 2013 issue of the journal Diabetologia, the study was led by Stephanie R. Johnson with the Department of Endocrinology and Diabetes at the Princess Margaret Hospital for Children in Perth, Australia.
“This is the largest study of insulin pump use in children. Our data confirm that insulin pump therapy provides an improvement in glycemic control, which is sustained for at least 7 years,” Johnson wrote.
Davis and her team compared outcomes for 345 children from ages 2 to 19 using insulin pumps to control type 1 diabetes, to around the same number of children who were receiving insulin injections. The researchers followed the children for an average of 3½ years.
They found that insulin pump therapy reduced severe hypoglycemia from 14.7 to 7.2 events per 100 patient-years. Conversely, severe hypoglycemia increased in the non-pump group from 6.8 to 10.2 events per 100 patient-years.
In addition, the rate of hospitalization for diabetic ketoacidosis was lower in the insulin pump group (2.3 versus 4.7 events).
“The increasing use of insulin pump therapy over the last 15 years, particularly in children, has been driven by improvements in pump technology and the availability of insulin analogues….Despite this increased use, the outcomes of pump therapy continue to be debated,” Johnson wrote.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More